1. Home
  2. VRE vs TRVI Comparison

VRE vs TRVI Comparison

Compare VRE & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veris Residential Inc.

VRE

Veris Residential Inc.

HOLD

Current Price

$18.99

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.46

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRE
TRVI
Founded
1949
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
VRE
TRVI
Price
$18.99
$14.46
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$19.50
$21.55
AVG Volume (30 Days)
956.6K
916.5K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
1.69%
N/A
EPS Growth
420.00
31.91
EPS
N/A
N/A
Revenue
$288,434,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.40
N/A
52 Week Low
$13.69
$5.41
52 Week High
$19.03
$16.12

Technical Indicators

Market Signals
Indicator
VRE
TRVI
Relative Strength Index (RSI) 65.35 56.04
Support Level $18.88 $10.07
Resistance Level $19.01 $14.57
Average True Range (ATR) 0.02 0.58
MACD -0.01 -0.03
Stochastic Oscillator 85.71 80.34

Price Performance

Historical Comparison
VRE
TRVI

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: